A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study

International Journal of Cancer

Volumn 133, Issue 11, 2013, Pages 2672-2680

  Lynch, Shannon M ^a,b   Major, Jacqueline M ^a   Cawthon, Richard ^c   Weinstein, Stephanie J ^a   Virtamo, Jarmo ^d   Lan, Qing ^a   Rothman, Nathaniel ^a   Albanes, Demetrius ^a   Stolzenberg Solomon, Rachael Z ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

biomarker; epidemiology; pancreatic cancer; telomere length

Indexed keywords

ADULT; AGED; BLOOD SAMPLING; CANCER RISK; CASE CONTROL STUDY; CAUSAL ATTRIBUTION; CHROMOSOME ANALYSIS; CHROMOSOME STRUCTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; TELOMERE LENGTH;

BIOMARKER; EPIDEMIOLOGY; PANCREATIC CANCER; TELOMERE LENGTH;

AGED; ALPHA-TOCOPHEROL; BETA CAROTENE; CASE-CONTROL STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TELOMERE HOMEOSTASIS;

EID: 84884900471     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28272     Document Type: Review

References (56)

1. Johns Hopkins University Center. Johns Hopkins and You. Participating in research specific to African Americans. Baltimore, MD: Johns Hopkins University Press, 2003.
2. American Cancer Society, Cancer Facts and Figures 2012, 2012.
3. Cheung ALM, Deng W,. Telomere dysfunction, genome instability and cancer. Front Biosci 2008; 13: 2075-90.
4. Londoño-Vallejo JA,. Telomere instability and cancer. Biochimie 2008; 90: 73-82.
5. Stewart SA, Bertuch AA,. The role of telomeres and telomerase in cancer research. Cancer Res 2010; 70: 7365-71.
6. Martinez P, Blasco MA,. Role of shelterin in cancer and aging. Aging Cell 2010; 9: 653-66.
7. Henson JD, Reddel RR,. Assaying and investigating alternative lengthening of telomeres activity in human cells and cancers. FEBS Lett 584: 3800-11.
8. Palm W, de Lange T,. How shelterin protects mammalian telomeres. Annu Rev Genet 2008; 42: 301-34.
9. Muñoz P, Blanco R, Blasco MA,. Role of the TRF2 telomeric protein in cancer and aging. Cell Cycle 2006; 5: 718-21.
10. Halvorsen T,. Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol 1999; 19: 1864-70.
11. Koorstra JBM, Hustinx SR, Offerhaus GJA, et al. Pancreatic carcinogenesis. Pancreatology 2008; 8: 110-25.
12. van Heek NT, Meeker AK, Kern SE, et al. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 2002; 161: 1541-47.
13. Hong S-M, Heaphy CM, Shi C, et al. Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias. Mod Pathol 2011; 24: 256-66.
14. Campbell PJ, Yachida S, Mudie LJ, et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010; 467: 1109-13.
15. Baird DM,. Variation at the TERT locus and predisposition for cancer. Exp Rev Mol Med 2010; 12: e16.
16. McGrath M, Wong JY, Michaud D, et al. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007; 16: 815-9.
17. Fitzpatrick AL, Kronmal RA, Gardner JP, et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 2007; 165: 14-21.
18. Lynch SM, Vrieling A, Lubin JH, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic Cancer Cohort Consortium. Am J Epidemiol 2009; 170: 403-13.
19. Zannolli R, Mohn A, Buoni S, et al. Telomere length and obesity. Acta Paediatr 2008; 97: 952-4.
20. Arslan AA, Helzlsouer KJ, Kooperberg C, et al. Anthropometric measures, body mass Index, and pancreatic cancer: A pooled analysis from the pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 2010; 170: 791-802.
21. Nettleton JA, Diez-Roux A, Jenny NS, et al. Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2008; 88: 1405-12.
22. Cherkas LF, Hunkin JL, Kato BS, et al. The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 2008; 168: 154-8.
23. Grote V, Rohrmann S, Nieters A, et al. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia 2011; 54: 3037-46.
24. Murillo-Ortiz B, Albarrán-Tamayo F, Arenas-Aranda D, et al. Telomere length and type 2 diabetes in males, a premature aging syndrome. Aging Male 2012; 15: 54-8.
25. Ma H, Zhou Z, Wei S, et al. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE 2011; 6: e20466.
26. Wentzensen IM, Mirabello L, Pfeiffer RM, et al. The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2011; 20: 1238-50.
27. The ATBC Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4: 1-10.
28. Korhonen P, Malila N, Pukkala E, et al. The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 2002; 41: 381-388.
29. Lan Q, Cawthon R, Shen M, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of Non-Hodgkin lymphoma. Clin Cancer Res 2009; 15: 7429-33.
30. Shen M, Cawthon R, Rothman N, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer 2011; 73: 133-37.
31. Cawthon RM,. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucl Acids Res 2009; 37: e21.
32. Arslan AA, Helzlsouer KJ, Kooperberg C, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 2010; 170: 791-802.
33. Genkinger JM, Spiegelman D, Anderson KE, et al. Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev 2009; 18: 765-76.
34. Jacobs EJ, Chanock SJ, Fuchs CS, et al. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer 2010; 127: 1421-8.
35. Jiao L, Berrington de Gonzalez A, Hartge P, et al. Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control 2010; 21: 1305-14.
36. Lynch SM, Vrieling A, Lubin JH, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol 2009; 170: 403-13.
37. Michaud DS, Vrieling A, Jiao L, et al. Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control 2010; 21: 1213-25.
38. Stolzenberg-Solomon RZ, Pietinen P, Barrett MJ, et al. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am J Epidemiol 2001; 153: 680-7.
39. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, et al. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 2002; 155: 783-92.
40. Willett WSM,. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986; 124: 17-27.
41. Hou L, Zhang X, Gawron AJ, et al. Surrogate tissue telomere length and cancer risk: shorter or longer? Cancer Lett 2012; 319: 130-35.
42. Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002; 3: 991-98.
43. Biegler KA, Anderson AKL, Wenzel LB, et al. Longitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: implications for cancer prevention. Cancer Prev Res 2012; 5: 1173-82.
44. Aladdin H, Katzenstein T, Dreves AM, et al. T-cell receptor excisional circles, telomere length, proliferation and apoptosis in peripheral blood mononuclear cells of human immunodeficiency virus-infected individuals after 18 months of treatment induced viral suppression. Scand J Immunol 2003; 57: 485-92.
45. Kaszubowska L,. Telomere shortening and ageing of the immune system. J Physiol Pharmacol 2008; 59: 169-86.
46. Eisenberg DTA,. An evolutionary review of human telomere biology: the thrifty telomere hypothesis and notes on potential adaptive paternal effects. Am J Hum Biol 2011; 23: 149-67.
47. Zamarron BF, Chen W,. Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci 2011; 7: 651-58.
48. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467: 1114-17.
49. Skinner HG, Gangnon RE, Litzelman K, et al. Telomere length and pancreatic cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 2012; 21: 2095-100.
50. Ishii A, Nakamura K-I, Kishimoto H, et al. Telomere shortening with aging in the human pancreas. Exp Gerontol 2006; 41: 882-86.
51. Hashimoto Y, Murakami Y, Uemura K, et al. Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas. J Gastrointest Surg 2008; 12: 17-29.
52. Matsubara Y, Murata M, Yoshida T, et al. Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochem Biophys Res Commun 2006; 341: 128-31.
53. Xing J, Ajani JA, Chen M, et al. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res 2009; 2: 459-65.
54. Hoffmann J, Erben Y, Zeiher AM, et al. Telomere length-heterogeneity among myeloid cells is a predictor for chronological ageing. Exp Gerontol 2009; 44: 363-66.
55. Spyridopoulos I, Erben Y, Brummendorf TH, et al. Telomere gap between granulocytes and lymphocytes is a determinant for hematopoetic progenitor cell impairment in patients with previous myocardial infarction. Arterioscler Thrombo Vasc Biol 2008; 28: 968-74.
56. Aviv A, Valdes AM, Spector TD,. Human telomere biology: pitfalls of moving from the laboratory to epidemiology. Int J Epidemiol 2006; 35: 1424-29.